IP Verse

Pluristem competitive analysis

Latest publications and patents of Pluristem New

Explore the latest publications and patents granted to Pluristem, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Pluristem
EP3103463	Jan 1, 2020	Adherent Cells From Adipose Or Placenta Tissues And Use Thereof In Therapy	Granted And Under Opposition
EP3091071	Jul 3, 2019	Methods For Cell Expansion And Uses Of Cells And Conditioned Media Produced Thereby For Therapy	Revoked

Latest patents of Pluristem opposed by its competitors

Explore Pluristem's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3103463	Jan 1, 2020	Adherent Cells From Adipose Or Placenta Tissues And Use Thereof In Therapy	2
EP3091071	Jul 3, 2019	Methods For Cell Expansion And Uses Of Cells And Conditioned Media Produced Thereby For Therapy	1

Latest PTAB cases involving Pluristem

Discover the latest PTAB cases involving Pluristem, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Pluristem with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
PLURISTEM	-	3	-	-	Non-Active
ICOSA EUROPE	2	-	-	-	Highly Aggressive
STRAWMAN	331	-	-	-	Highly Aggressive